NCT02828319View on ClinicalTrials.gov

Clinical Study of Z-213 in Subjects With Iron-deficiency Anemia

PHASE3CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

May 31, 2017

Study Completion Date

December 31, 2017

Conditions
Iron Deficiency Anemia
Interventions
DRUG

Z-213

The total iron dosage is calculated based on hemoglobin value and the patients' weight, IV on day 1, 8 and 15 (if needed)

Trial Locations (1)

Unknown

Tokyo

Sponsors
All Listed Sponsors
lead

Zeria Pharmaceutical

INDUSTRY